371754-23-3

Basic information

• Product Name: Carbamic acid, [(2R)-2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]methyl-, 4-[bis(2-chloroethyl)amino]phenyl ester
• CAS NO: 371754-23-3
• Molecular Formula: C20H24Cl2N2O5
• Molecular Weight: 443.327
• Mol File: 371754-23-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [(2R)-2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]methyl-, 4-[bis(2-chloroethyl)amino]phenyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(2R)-2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]methyl-, 4-[bis(2-chloroethyl)amino]phenyl ester(371754-23-3)
• EPA Substance Registry System: Carbamic acid, [(2R)-2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]methyl-, 4-[bis(2-chloroethyl)amino]phenyl ester(371754-23-3)

Safety Data

• Hazardous Substances Data: 371754-23-3(Hazardous Substances Data)

Upstream product

• 1457-06-3 4-[N,N-bis(2-chloroethyl)amino]phenol hydrochloride 
• 51388-20-6 4-benzyloxyaniline hydrochloride 
• 17794-35-3 benzyl-p-(bis-2-chloroethylamino)phenyl ester 
• 101582-69-8 4--O-benzylphenol 
• 51-43-4 L-epinephrine 

Relevant articles and documents

Melanocyte-directed enzyme prodrug therapy (MDEPT): Development of second generation prodrugs for targeted treatment of malignant melanoma

Evaluation of second generation prodrugs for MDEPT, by oximetry, has highlighted structural properties that are advantageous and disadvantageous for efficient oxidation using mushroom tyrosinase. In particular, a sterically undemanding prodrug bis-(2-chlo